BiotechTube
Liferiver Bio-Tech Corp

Liferiver Bio-Tech Corp

San Diego, United States· Est.
liferiverbiotech.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $42M

Overview

Liferiver Bio-Tech Corp is a privately-held diagnostics company established in 2009, operating from San Diego, USA. It has built a business around developing and commercializing genetic diagnostic reagents and the associated instrumentation, positioning itself as a key supplier in the molecular diagnostics space. The company is revenue-generating with a commercial-stage portfolio, catering primarily to the diagnostics market. Its focus is on leveraging genetic analysis to enable disease detection and monitoring.

Infectious DiseaseOncologyGenetic Disorders

Technology Platform

Platform for developing and manufacturing genetic diagnostic reagents and integrated instruments, focusing on PCR and other nucleic acid amplification technologies.

Funding History

2
Total raised:$42M
Series B$30M
Series A$12M

Opportunities

The growing global molecular diagnostics market, driven by personalized medicine and infectious disease surveillance, presents a major expansion opportunity.
Decentralization of testing and the rise of liquid biopsy in oncology create demand for robust, scalable reagent systems.
Expansion into next-generation sequencing (NGS) reagents could open new, high-growth market segments.

Risk Factors

The company faces intense competition from large, established diagnostics conglomerates and low-cost manufacturers.
Technological disruption and rapid shifts in testing methodologies could threaten existing product lines.
Geopolitical tensions and supply chain fragility, especially related to biomanufacturing between the US and China, pose significant operational and strategic risks.

Competitive Landscape

Liferiver competes in a crowded and fragmented market dominated by giants like Thermo Fisher, Qiagen, Roche, and Bio-Rad, which offer comprehensive diagnostic systems. It also faces competition from numerous specialized and low-cost reagent manufacturers, particularly in Asia. Success depends on competing on price, quality, supply reliability, and technical support.

More companies in Diagnostics & Precision Medicine →More companies in United States →